Atea Pharmaceuticals, Inc. - stock earnings
AVIR Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -39.2 million USD | ? USD |
| 2023Q3 | -33.1 million USD | ? USD |
| 2023Q2 | -28.2 million USD | ? USD |
| 2023Q1 | -35.5 million USD | ? USD |
| 2022Q4 | -34.4 million USD | ? USD |
| 2022Q3 | -8.1 million USD | ? USD |
| 2022Q2 | -31.3 million USD | ? USD |
| 2022Q1 | -42.0 million USD | ? USD |
| 2021Q4 | 117.1 million USD | 192.2 million USD |
| 2021Q3 | -28.2 million USD | 32.8 million USD |
| 2021Q2 | 1.5 million USD | 60.4 million USD |
| 2021Q1 | 30.7 million USD | 66.0 million USD |
| 2020Q4 | 20.7 million USD | 48.6 million USD |
| 2020Q3 | -17.6 million USD | ? USD |
| 2020Q2 | -10.0 million USD | ? USD |
| 2020Q1 | -4.0 million USD | ? USD |
| 2019Q4 | -4.7 million USD | ? USD |
| 2019Q3 | -3.6 million USD | ? USD |
| 2019Q2 | -3.5 million USD | ? USD |
| 2019Q1 | -3.5 million USD | ? USD |
| 2018Q4 | -3.5 million USD | ? USD |
| 2018Q2 | -2.3 million USD | ? USD |
| 2018Q1 | -2.3 million USD | ? USD |
| 2017Q4 | -2.3 million USD | ? USD |
AVIR Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -136.0 million USD | ? USD |
| 2022 | -115.9 million USD | 192.2 million USD |
| 2021 | 121.2 million USD | 351.4 million USD |
| 2020 | -10.9 million USD | 48.6 million USD |
| 2019 | -13.5 million USD | ? USD |
| 2018 | -9.1 million USD | ? USD |
AVIR
Price: $3.71
52 week price:
Earnings Per Share: -1.63 USD
P/E Ratio: -2.56
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 884000
Ebitda: -17.0 millionMarket Capitalization: 316.9 million